C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer-Reference-Cited by-同舟云学术

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer

Published:2023-09-30 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Chen¹,Cao Kankan¹,Yang Moran¹,Wang Yiying¹,He Mengdi¹,Lu Jiaqi²,Huang Yan³,Zhang Guodong¹²,Liu Haiou¹^ORCID

Affiliation:

1. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

2. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

3. Department of Gynecologic Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai

Shanghai Sailing Program

Foundation of Science and Technology Commission of Shanghai Municipality

Shanghai Clinical Research Center for Gynecological Disease

Shanghai Urogenital System Disease Research Center

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2261242

Reference52 articles.

1. Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

2. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

3. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

4. Evolving synergistic combinations of targeted immunotherapies to combat cancer

5. The role of the anaphylatoxins in health and disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complement system as a target in cancer immunotherapy;European Journal of Immunology;2024-07-12

2. Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer;Cell Death & Disease;2024-05-10

3. Uncovering mechanisms underlying complement-mediated cancer immune evasion;Molecular Therapy;2024-02

4. The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context;Frontiers in Immunology;2024-01-17

5. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a;Journal of Ovarian Research;2024-01-05